Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Cost of Revenue (2016 - 2025)

Marimed has reported Cost of Revenue over the past 15 years, most recently at $31.1 million for Q4 2025.

  • Quarterly Cost of Revenue rose 18.46% to $31.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101.9 million through Dec 2025, up 7.2% year-over-year, with the annual reading at $101.9 million for FY2025, 7.2% up from the prior year.
  • Cost of Revenue was $31.1 million for Q4 2025 at Marimed, up from $24.4 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $31.1 million in Q4 2025 and troughed at $11.5 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $20.8 million (2023), against an average of $20.2 million.
  • Year-over-year, Cost of Revenue soared 341.01% in 2021 and then increased 0.21% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $15.6 million in 2021, then grew by 28.7% to $20.0 million in 2022, then grew by 7.81% to $21.6 million in 2023, then rose by 21.83% to $26.3 million in 2024, then grew by 18.46% to $31.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Cost of Revenue are $31.1 million (Q4 2025), $24.4 million (Q3 2025), and $23.6 million (Q2 2025).